nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0603	0.0807	CbGbCtD
Buspirone—CYP3A7—Simvastatin—atherosclerosis	0.0603	0.0807	CbGbCtD
Buspirone—CYP3A7—Lovastatin—atherosclerosis	0.059	0.079	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.059	0.079	CbGbCtD
Buspirone—CYP3A5—Rosuvastatin—atherosclerosis	0.0486	0.0651	CbGbCtD
Buspirone—CYP3A5—Simvastatin—atherosclerosis	0.0452	0.0605	CbGbCtD
Buspirone—CYP3A5—Lovastatin—atherosclerosis	0.0442	0.0592	CbGbCtD
Buspirone—CYP3A5—Pravastatin—atherosclerosis	0.0442	0.0592	CbGbCtD
Buspirone—CYP2D6—Niacin—atherosclerosis	0.0351	0.047	CbGbCtD
Buspirone—ABCB1—Ezetimibe—atherosclerosis	0.0317	0.0424	CbGbCtD
Buspirone—ABCB1—Simvastatin—atherosclerosis	0.0294	0.0394	CbGbCtD
Buspirone—ABCB1—Pravastatin—atherosclerosis	0.0288	0.0386	CbGbCtD
Buspirone—ABCB1—Lovastatin—atherosclerosis	0.0288	0.0386	CbGbCtD
Buspirone—CYP2D6—Simvastatin—atherosclerosis	0.0277	0.0371	CbGbCtD
Buspirone—CYP2D6—Pravastatin—atherosclerosis	0.0271	0.0363	CbGbCtD
Buspirone—CYP2D6—Lovastatin—atherosclerosis	0.0271	0.0363	CbGbCtD
Buspirone—CYP3A4—Ezetimibe—atherosclerosis	0.019	0.0254	CbGbCtD
Buspirone—CYP3A4—Rosuvastatin—atherosclerosis	0.019	0.0254	CbGbCtD
Buspirone—CYP3A4—Simvastatin—atherosclerosis	0.0176	0.0236	CbGbCtD
Buspirone—CYP3A4—Lovastatin—atherosclerosis	0.0173	0.0231	CbGbCtD
Buspirone—CYP3A4—Pravastatin—atherosclerosis	0.0173	0.0231	CbGbCtD
Buspirone—HTR2A—arteriole—atherosclerosis	0.00237	0.222	CbGeAlD
Buspirone—HTR2A—vein—atherosclerosis	0.00141	0.133	CbGeAlD
Buspirone—HTR2A—hindlimb—atherosclerosis	0.000937	0.0881	CbGeAlD
Buspirone—HTR2A—appendage—atherosclerosis	0.000804	0.0756	CbGeAlD
Buspirone—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000653	0.00405	CcSEcCtD
Buspirone—Flushing—Lovastatin—atherosclerosis	0.000652	0.00405	CcSEcCtD
Buspirone—Myocardial infarction—Pravastatin—atherosclerosis	0.000649	0.00403	CcSEcCtD
Buspirone—Sweating—Niacin—atherosclerosis	0.000645	0.004	CcSEcCtD
Buspirone—Flushing—Ezetimibe—atherosclerosis	0.00064	0.00397	CcSEcCtD
Buspirone—Chills—Lovastatin—atherosclerosis	0.000631	0.00391	CcSEcCtD
Buspirone—Alopecia—Lovastatin—atherosclerosis	0.000621	0.00385	CcSEcCtD
Buspirone—Myalgia—Rosuvastatin—atherosclerosis	0.000615	0.00381	CcSEcCtD
Buspirone—Arthralgia—Rosuvastatin—atherosclerosis	0.000615	0.00381	CcSEcCtD
Buspirone—Flushing—Simvastatin—atherosclerosis	0.00061	0.00378	CcSEcCtD
Buspirone—Alopecia—Ezetimibe—atherosclerosis	0.000609	0.00378	CcSEcCtD
Buspirone—Haemoglobin—Niacin—atherosclerosis	0.000607	0.00376	CcSEcCtD
Buspirone—Haemorrhage—Niacin—atherosclerosis	0.000604	0.00374	CcSEcCtD
Buspirone—Flatulence—Lovastatin—atherosclerosis	0.000603	0.00374	CcSEcCtD
Buspirone—Hypoaesthesia—Niacin—atherosclerosis	0.000601	0.00373	CcSEcCtD
Buspirone—Erythema—Ezetimibe—atherosclerosis	0.0006	0.00372	CcSEcCtD
Buspirone—Dysgeusia—Lovastatin—atherosclerosis	0.000599	0.00372	CcSEcCtD
Buspirone—Confusional state—Rosuvastatin—atherosclerosis	0.000594	0.00369	CcSEcCtD
Buspirone—Hypoaesthesia—Pravastatin—atherosclerosis	0.000591	0.00367	CcSEcCtD
Buspirone—Flatulence—Ezetimibe—atherosclerosis	0.000591	0.00367	CcSEcCtD
Buspirone—Chills—Simvastatin—atherosclerosis	0.00059	0.00366	CcSEcCtD
Buspirone—Muscle spasms—Lovastatin—atherosclerosis	0.000588	0.00365	CcSEcCtD
Buspirone—Alopecia—Simvastatin—atherosclerosis	0.000581	0.0036	CcSEcCtD
Buspirone—Muscle spasms—Ezetimibe—atherosclerosis	0.000577	0.00358	CcSEcCtD
Buspirone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000577	0.00358	CcSEcCtD
Buspirone—Vision blurred—Lovastatin—atherosclerosis	0.000577	0.00358	CcSEcCtD
Buspirone—HTR2A—artery—atherosclerosis	0.000575	0.054	CbGeAlD
Buspirone—Tremor—Lovastatin—atherosclerosis	0.000573	0.00356	CcSEcCtD
Buspirone—Erythema—Simvastatin—atherosclerosis	0.000572	0.00355	CcSEcCtD
Buspirone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000568	0.00352	CcSEcCtD
Buspirone—Flatulence—Simvastatin—atherosclerosis	0.000564	0.0035	CcSEcCtD
Buspirone—Tinnitus—Niacin—atherosclerosis	0.000563	0.00349	CcSEcCtD
Buspirone—Dysgeusia—Simvastatin—atherosclerosis	0.000561	0.00348	CcSEcCtD
Buspirone—Flushing—Niacin—atherosclerosis	0.00056	0.00347	CcSEcCtD
Buspirone—Angioedema—Lovastatin—atherosclerosis	0.000559	0.00347	CcSEcCtD
Buspirone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000557	0.00345	CcSEcCtD
Buspirone—Tinnitus—Pravastatin—atherosclerosis	0.000554	0.00344	CcSEcCtD
Buspirone—Malaise—Lovastatin—atherosclerosis	0.000552	0.00342	CcSEcCtD
Buspirone—Flushing—Pravastatin—atherosclerosis	0.000552	0.00342	CcSEcCtD
Buspirone—Muscle spasms—Simvastatin—atherosclerosis	0.00055	0.00341	CcSEcCtD
Buspirone—Vertigo—Lovastatin—atherosclerosis	0.00055	0.00341	CcSEcCtD
Buspirone—Angioedema—Ezetimibe—atherosclerosis	0.000548	0.0034	CcSEcCtD
Buspirone—Leukopenia—Lovastatin—atherosclerosis	0.000548	0.0034	CcSEcCtD
Buspirone—Chills—Niacin—atherosclerosis	0.000542	0.00336	CcSEcCtD
Buspirone—Malaise—Ezetimibe—atherosclerosis	0.000541	0.00336	CcSEcCtD
Buspirone—Vision blurred—Simvastatin—atherosclerosis	0.000539	0.00335	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000537	0.00333	CcSEcCtD
Buspirone—Tremor—Simvastatin—atherosclerosis	0.000536	0.00333	CcSEcCtD
Buspirone—Alopecia—Niacin—atherosclerosis	0.000534	0.00331	CcSEcCtD
Buspirone—Chills—Pravastatin—atherosclerosis	0.000533	0.00331	CcSEcCtD
Buspirone—Insomnia—Rosuvastatin—atherosclerosis	0.000533	0.00331	CcSEcCtD
Buspirone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000531	0.00329	CcSEcCtD
Buspirone—Palpitations—Ezetimibe—atherosclerosis	0.00053	0.00329	CcSEcCtD
Buspirone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000529	0.00328	CcSEcCtD
Buspirone—Erythema—Niacin—atherosclerosis	0.000526	0.00326	CcSEcCtD
Buspirone—Alopecia—Pravastatin—atherosclerosis	0.000525	0.00326	CcSEcCtD
Buspirone—Angioedema—Simvastatin—atherosclerosis	0.000523	0.00324	CcSEcCtD
Buspirone—Myalgia—Lovastatin—atherosclerosis	0.000521	0.00323	CcSEcCtD
Buspirone—Arthralgia—Lovastatin—atherosclerosis	0.000521	0.00323	CcSEcCtD
Buspirone—Chest pain—Lovastatin—atherosclerosis	0.000521	0.00323	CcSEcCtD
Buspirone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000519	0.00322	CcSEcCtD
Buspirone—Hypertension—Ezetimibe—atherosclerosis	0.000518	0.00321	CcSEcCtD
Buspirone—Flatulence—Niacin—atherosclerosis	0.000518	0.00321	CcSEcCtD
Buspirone—Malaise—Simvastatin—atherosclerosis	0.000516	0.0032	CcSEcCtD
Buspirone—Tension—Niacin—atherosclerosis	0.000516	0.0032	CcSEcCtD
Buspirone—Discomfort—Lovastatin—atherosclerosis	0.000515	0.00319	CcSEcCtD
Buspirone—Vertigo—Simvastatin—atherosclerosis	0.000514	0.00319	CcSEcCtD
Buspirone—Leukopenia—Simvastatin—atherosclerosis	0.000512	0.00318	CcSEcCtD
Buspirone—Myalgia—Ezetimibe—atherosclerosis	0.000511	0.00317	CcSEcCtD
Buspirone—Chest pain—Ezetimibe—atherosclerosis	0.000511	0.00317	CcSEcCtD
Buspirone—Arthralgia—Ezetimibe—atherosclerosis	0.000511	0.00317	CcSEcCtD
Buspirone—Nervousness—Niacin—atherosclerosis	0.00051	0.00317	CcSEcCtD
Buspirone—Flatulence—Pravastatin—atherosclerosis	0.00051	0.00316	CcSEcCtD
Buspirone—Dry mouth—Lovastatin—atherosclerosis	0.00051	0.00316	CcSEcCtD
Buspirone—Tension—Pravastatin—atherosclerosis	0.000508	0.00315	CcSEcCtD
Buspirone—Dysgeusia—Pravastatin—atherosclerosis	0.000507	0.00314	CcSEcCtD
Buspirone—Muscle spasms—Niacin—atherosclerosis	0.000505	0.00313	CcSEcCtD
Buspirone—Discomfort—Ezetimibe—atherosclerosis	0.000505	0.00313	CcSEcCtD
Buspirone—Constipation—Rosuvastatin—atherosclerosis	0.000504	0.00313	CcSEcCtD
Buspirone—Pain—Rosuvastatin—atherosclerosis	0.000504	0.00313	CcSEcCtD
Buspirone—Confusional state—Lovastatin—atherosclerosis	0.000504	0.00312	CcSEcCtD
Buspirone—Nervousness—Pravastatin—atherosclerosis	0.000503	0.00312	CcSEcCtD
Buspirone—Dry mouth—Ezetimibe—atherosclerosis	0.0005	0.0031	CcSEcCtD
Buspirone—Muscle spasms—Pravastatin—atherosclerosis	0.000498	0.00309	CcSEcCtD
Buspirone—Vision blurred—Niacin—atherosclerosis	0.000495	0.00307	CcSEcCtD
Buspirone—Confusional state—Ezetimibe—atherosclerosis	0.000494	0.00306	CcSEcCtD
Buspirone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000489	0.00303	CcSEcCtD
Buspirone—Vision blurred—Pravastatin—atherosclerosis	0.000488	0.00302	CcSEcCtD
Buspirone—Arthralgia—Simvastatin—atherosclerosis	0.000487	0.00302	CcSEcCtD
Buspirone—Chest pain—Simvastatin—atherosclerosis	0.000487	0.00302	CcSEcCtD
Buspirone—Myalgia—Simvastatin—atherosclerosis	0.000487	0.00302	CcSEcCtD
Buspirone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000486	0.00301	CcSEcCtD
Buspirone—HTR2A—endothelium—atherosclerosis	0.000485	0.0456	CbGeAlD
Buspirone—Tremor—Pravastatin—atherosclerosis	0.000485	0.00301	CcSEcCtD
Buspirone—Discomfort—Simvastatin—atherosclerosis	0.000481	0.00299	CcSEcCtD
Buspirone—Angioedema—Niacin—atherosclerosis	0.00048	0.00298	CcSEcCtD
Buspirone—Ill-defined disorder—Pravastatin—atherosclerosis	0.00048	0.00298	CcSEcCtD
Buspirone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00048	0.00297	CcSEcCtD
Buspirone—Anorexia—Lovastatin—atherosclerosis	0.000476	0.00295	CcSEcCtD
Buspirone—Angioedema—Pravastatin—atherosclerosis	0.000473	0.00293	CcSEcCtD
Buspirone—Vertigo—Niacin—atherosclerosis	0.000472	0.00293	CcSEcCtD
Buspirone—Syncope—Niacin—atherosclerosis	0.000471	0.00292	CcSEcCtD
Buspirone—Confusional state—Simvastatin—atherosclerosis	0.000471	0.00292	CcSEcCtD
Buspirone—Leukopenia—Niacin—atherosclerosis	0.00047	0.00292	CcSEcCtD
Buspirone—Urticaria—Rosuvastatin—atherosclerosis	0.000468	0.0029	CcSEcCtD
Buspirone—Oedema—Simvastatin—atherosclerosis	0.000467	0.0029	CcSEcCtD
Buspirone—Malaise—Pravastatin—atherosclerosis	0.000467	0.00289	CcSEcCtD
Buspirone—Vertigo—Pravastatin—atherosclerosis	0.000465	0.00288	CcSEcCtD
Buspirone—Palpitations—Niacin—atherosclerosis	0.000464	0.00288	CcSEcCtD
Buspirone—Leukopenia—Pravastatin—atherosclerosis	0.000463	0.00287	CcSEcCtD
Buspirone—Loss of consciousness—Niacin—atherosclerosis	0.000462	0.00286	CcSEcCtD
Buspirone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000457	0.00284	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000455	0.00282	CcSEcCtD
Buspirone—Insomnia—Lovastatin—atherosclerosis	0.000452	0.0028	CcSEcCtD
Buspirone—Paraesthesia—Lovastatin—atherosclerosis	0.000448	0.00278	CcSEcCtD
Buspirone—HTR2A—blood vessel—atherosclerosis	0.000448	0.0421	CbGeAlD
Buspirone—Myalgia—Niacin—atherosclerosis	0.000447	0.00277	CcSEcCtD
Buspirone—Arthralgia—Niacin—atherosclerosis	0.000447	0.00277	CcSEcCtD
Buspirone—Hypertension—Pravastatin—atherosclerosis	0.000447	0.00277	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000446	0.00277	CcSEcCtD
Buspirone—Anorexia—Simvastatin—atherosclerosis	0.000445	0.00276	CcSEcCtD
Buspirone—Dyspnoea—Lovastatin—atherosclerosis	0.000445	0.00276	CcSEcCtD
Buspirone—Insomnia—Ezetimibe—atherosclerosis	0.000443	0.00275	CcSEcCtD
Buspirone—Chest pain—Pravastatin—atherosclerosis	0.000441	0.00273	CcSEcCtD
Buspirone—Arthralgia—Pravastatin—atherosclerosis	0.000441	0.00273	CcSEcCtD
Buspirone—Myalgia—Pravastatin—atherosclerosis	0.000441	0.00273	CcSEcCtD
Buspirone—Paraesthesia—Ezetimibe—atherosclerosis	0.00044	0.00273	CcSEcCtD
Buspirone—Dyspepsia—Lovastatin—atherosclerosis	0.00044	0.00273	CcSEcCtD
Buspirone—Dry mouth—Niacin—atherosclerosis	0.000438	0.00271	CcSEcCtD
Buspirone—Dyspnoea—Ezetimibe—atherosclerosis	0.000437	0.00271	CcSEcCtD
Buspirone—Discomfort—Pravastatin—atherosclerosis	0.000435	0.0027	CcSEcCtD
Buspirone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000434	0.00269	CcSEcCtD
Buspirone—Decreased appetite—Lovastatin—atherosclerosis	0.000434	0.00269	CcSEcCtD
Buspirone—CYP3A7—liver—atherosclerosis	0.000433	0.0407	CbGeAlD
Buspirone—Dyspepsia—Ezetimibe—atherosclerosis	0.000431	0.00267	CcSEcCtD
Buspirone—Fatigue—Lovastatin—atherosclerosis	0.000431	0.00267	CcSEcCtD
Buspirone—Oedema—Niacin—atherosclerosis	0.000429	0.00266	CcSEcCtD
Buspirone—Constipation—Lovastatin—atherosclerosis	0.000427	0.00265	CcSEcCtD
Buspirone—Pain—Lovastatin—atherosclerosis	0.000427	0.00265	CcSEcCtD
Buspirone—Confusional state—Pravastatin—atherosclerosis	0.000426	0.00264	CcSEcCtD
Buspirone—Decreased appetite—Ezetimibe—atherosclerosis	0.000426	0.00264	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000426	0.00264	CcSEcCtD
Buspirone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000423	0.00262	CcSEcCtD
Buspirone—Asthenia—Rosuvastatin—atherosclerosis	0.000423	0.00262	CcSEcCtD
Buspirone—Insomnia—Simvastatin—atherosclerosis	0.000423	0.00262	CcSEcCtD
Buspirone—Oedema—Pravastatin—atherosclerosis	0.000422	0.00262	CcSEcCtD
Buspirone—Fatigue—Ezetimibe—atherosclerosis	0.000422	0.00262	CcSEcCtD
Buspirone—Shock—Niacin—atherosclerosis	0.000422	0.00262	CcSEcCtD
Buspirone—Paraesthesia—Simvastatin—atherosclerosis	0.000419	0.0026	CcSEcCtD
Buspirone—Pain—Ezetimibe—atherosclerosis	0.000419	0.0026	CcSEcCtD
Buspirone—Constipation—Ezetimibe—atherosclerosis	0.000419	0.0026	CcSEcCtD
Buspirone—Tachycardia—Niacin—atherosclerosis	0.000419	0.0026	CcSEcCtD
Buspirone—Pruritus—Rosuvastatin—atherosclerosis	0.000417	0.00259	CcSEcCtD
Buspirone—Dyspnoea—Simvastatin—atherosclerosis	0.000416	0.00258	CcSEcCtD
Buspirone—Hyperhidrosis—Niacin—atherosclerosis	0.000415	0.00257	CcSEcCtD
Buspirone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000414	0.00256	CcSEcCtD
Buspirone—Feeling abnormal—Lovastatin—atherosclerosis	0.000412	0.00255	CcSEcCtD
Buspirone—Dyspepsia—Simvastatin—atherosclerosis	0.000411	0.00255	CcSEcCtD
Buspirone—Anorexia—Niacin—atherosclerosis	0.000409	0.00254	CcSEcCtD
Buspirone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000408	0.00253	CcSEcCtD
Buspirone—Decreased appetite—Simvastatin—atherosclerosis	0.000406	0.00252	CcSEcCtD
Buspirone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000404	0.0025	CcSEcCtD
Buspirone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000403	0.0025	CcSEcCtD
Buspirone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000403	0.0025	CcSEcCtD
Buspirone—Fatigue—Simvastatin—atherosclerosis	0.000403	0.0025	CcSEcCtD
Buspirone—Anorexia—Pravastatin—atherosclerosis	0.000403	0.0025	CcSEcCtD
Buspirone—Hypotension—Niacin—atherosclerosis	0.000401	0.00249	CcSEcCtD
Buspirone—Constipation—Simvastatin—atherosclerosis	0.000399	0.00248	CcSEcCtD
Buspirone—Pain—Simvastatin—atherosclerosis	0.000399	0.00248	CcSEcCtD
Buspirone—Urticaria—Lovastatin—atherosclerosis	0.000397	0.00246	CcSEcCtD
Buspirone—Body temperature increased—Lovastatin—atherosclerosis	0.000395	0.00245	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000391	0.00242	CcSEcCtD
Buspirone—Dizziness—Rosuvastatin—atherosclerosis	0.00039	0.00242	CcSEcCtD
Buspirone—Urticaria—Ezetimibe—atherosclerosis	0.000389	0.00241	CcSEcCtD
Buspirone—Insomnia—Niacin—atherosclerosis	0.000388	0.00241	CcSEcCtD
Buspirone—Body temperature increased—Ezetimibe—atherosclerosis	0.000387	0.0024	CcSEcCtD
Buspirone—Paraesthesia—Niacin—atherosclerosis	0.000385	0.00239	CcSEcCtD
Buspirone—Feeling abnormal—Simvastatin—atherosclerosis	0.000385	0.00239	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000385	0.00239	CcSEcCtD
Buspirone—Dyspnoea—Niacin—atherosclerosis	0.000382	0.00237	CcSEcCtD
Buspirone—Insomnia—Pravastatin—atherosclerosis	0.000382	0.00237	CcSEcCtD
Buspirone—Somnolence—Niacin—atherosclerosis	0.000381	0.00236	CcSEcCtD
Buspirone—Paraesthesia—Pravastatin—atherosclerosis	0.000379	0.00235	CcSEcCtD
Buspirone—Dyspepsia—Niacin—atherosclerosis	0.000378	0.00234	CcSEcCtD
Buspirone—Dyspnoea—Pravastatin—atherosclerosis	0.000377	0.00234	CcSEcCtD
Buspirone—HTR2B—cardiovascular system—atherosclerosis	0.000374	0.0352	CbGeAlD
Buspirone—Decreased appetite—Niacin—atherosclerosis	0.000373	0.00231	CcSEcCtD
Buspirone—Dyspepsia—Pravastatin—atherosclerosis	0.000372	0.00231	CcSEcCtD
Buspirone—Rash—Rosuvastatin—atherosclerosis	0.000372	0.0023	CcSEcCtD
Buspirone—Dermatitis—Rosuvastatin—atherosclerosis	0.000371	0.0023	CcSEcCtD
Buspirone—Urticaria—Simvastatin—atherosclerosis	0.000371	0.0023	CcSEcCtD
Buspirone—Gastrointestinal disorder—Niacin—atherosclerosis	0.00037	0.0023	CcSEcCtD
Buspirone—Body temperature increased—Simvastatin—atherosclerosis	0.000369	0.00229	CcSEcCtD
Buspirone—Headache—Rosuvastatin—atherosclerosis	0.000369	0.00229	CcSEcCtD
Buspirone—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000368	0.0346	CbGeAlD
Buspirone—Hypersensitivity—Lovastatin—atherosclerosis	0.000368	0.00228	CcSEcCtD
Buspirone—Decreased appetite—Pravastatin—atherosclerosis	0.000367	0.00228	CcSEcCtD
Buspirone—Pain—Niacin—atherosclerosis	0.000367	0.00227	CcSEcCtD
Buspirone—Fatigue—Pravastatin—atherosclerosis	0.000364	0.00226	CcSEcCtD
Buspirone—Pain—Pravastatin—atherosclerosis	0.000361	0.00224	CcSEcCtD
Buspirone—Constipation—Pravastatin—atherosclerosis	0.000361	0.00224	CcSEcCtD
Buspirone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000361	0.00224	CcSEcCtD
Buspirone—Asthenia—Lovastatin—atherosclerosis	0.000358	0.00222	CcSEcCtD
Buspirone—Pruritus—Lovastatin—atherosclerosis	0.000353	0.00219	CcSEcCtD
Buspirone—Asthenia—Ezetimibe—atherosclerosis	0.000351	0.00218	CcSEcCtD
Buspirone—Nausea—Rosuvastatin—atherosclerosis	0.00035	0.00217	CcSEcCtD
Buspirone—Feeling abnormal—Pravastatin—atherosclerosis	0.000348	0.00216	CcSEcCtD
Buspirone—Pruritus—Ezetimibe—atherosclerosis	0.000347	0.00215	CcSEcCtD
Buspirone—Hypersensitivity—Simvastatin—atherosclerosis	0.000344	0.00213	CcSEcCtD
Buspirone—Diarrhoea—Lovastatin—atherosclerosis	0.000342	0.00212	CcSEcCtD
Buspirone—Urticaria—Niacin—atherosclerosis	0.000341	0.00211	CcSEcCtD
Buspirone—Body temperature increased—Niacin—atherosclerosis	0.000339	0.0021	CcSEcCtD
Buspirone—Urticaria—Pravastatin—atherosclerosis	0.000336	0.00208	CcSEcCtD
Buspirone—Asthenia—Simvastatin—atherosclerosis	0.000335	0.00208	CcSEcCtD
Buspirone—Diarrhoea—Ezetimibe—atherosclerosis	0.000335	0.00208	CcSEcCtD
Buspirone—HTR1A—cardiovascular system—atherosclerosis	0.000335	0.0315	CbGeAlD
Buspirone—Body temperature increased—Pravastatin—atherosclerosis	0.000334	0.00207	CcSEcCtD
Buspirone—Pruritus—Simvastatin—atherosclerosis	0.00033	0.00205	CcSEcCtD
Buspirone—Dizziness—Lovastatin—atherosclerosis	0.00033	0.00205	CcSEcCtD
Buspirone—HTR2B—adipose tissue—atherosclerosis	0.00033	0.031	CbGeAlD
Buspirone—Dizziness—Ezetimibe—atherosclerosis	0.000324	0.00201	CcSEcCtD
Buspirone—Diarrhoea—Simvastatin—atherosclerosis	0.00032	0.00198	CcSEcCtD
Buspirone—Vomiting—Lovastatin—atherosclerosis	0.000318	0.00197	CcSEcCtD
Buspirone—Hypersensitivity—Niacin—atherosclerosis	0.000316	0.00196	CcSEcCtD
Buspirone—Rash—Lovastatin—atherosclerosis	0.000315	0.00195	CcSEcCtD
Buspirone—Dermatitis—Lovastatin—atherosclerosis	0.000315	0.00195	CcSEcCtD
Buspirone—Headache—Lovastatin—atherosclerosis	0.000313	0.00194	CcSEcCtD
Buspirone—Vomiting—Ezetimibe—atherosclerosis	0.000311	0.00193	CcSEcCtD
Buspirone—Hypersensitivity—Pravastatin—atherosclerosis	0.000311	0.00193	CcSEcCtD
Buspirone—Dizziness—Simvastatin—atherosclerosis	0.000309	0.00192	CcSEcCtD
Buspirone—Rash—Ezetimibe—atherosclerosis	0.000309	0.00192	CcSEcCtD
Buspirone—Dermatitis—Ezetimibe—atherosclerosis	0.000309	0.00191	CcSEcCtD
Buspirone—Asthenia—Niacin—atherosclerosis	0.000308	0.00191	CcSEcCtD
Buspirone—Headache—Ezetimibe—atherosclerosis	0.000307	0.0019	CcSEcCtD
Buspirone—Pruritus—Niacin—atherosclerosis	0.000303	0.00188	CcSEcCtD
Buspirone—Asthenia—Pravastatin—atherosclerosis	0.000303	0.00188	CcSEcCtD
Buspirone—Pruritus—Pravastatin—atherosclerosis	0.000299	0.00185	CcSEcCtD
Buspirone—Vomiting—Simvastatin—atherosclerosis	0.000297	0.00184	CcSEcCtD
Buspirone—Nausea—Lovastatin—atherosclerosis	0.000297	0.00184	CcSEcCtD
Buspirone—Rash—Simvastatin—atherosclerosis	0.000295	0.00183	CcSEcCtD
Buspirone—Dermatitis—Simvastatin—atherosclerosis	0.000294	0.00182	CcSEcCtD
Buspirone—Diarrhoea—Niacin—atherosclerosis	0.000293	0.00182	CcSEcCtD
Buspirone—ABCB1—blood vessel—atherosclerosis	0.000293	0.0276	CbGeAlD
Buspirone—Headache—Simvastatin—atherosclerosis	0.000293	0.00181	CcSEcCtD
Buspirone—Nausea—Ezetimibe—atherosclerosis	0.000291	0.0018	CcSEcCtD
Buspirone—Diarrhoea—Pravastatin—atherosclerosis	0.000289	0.00179	CcSEcCtD
Buspirone—Dizziness—Niacin—atherosclerosis	0.000284	0.00176	CcSEcCtD
Buspirone—Dizziness—Pravastatin—atherosclerosis	0.000279	0.00173	CcSEcCtD
Buspirone—Nausea—Simvastatin—atherosclerosis	0.000277	0.00172	CcSEcCtD
Buspirone—Vomiting—Niacin—atherosclerosis	0.000273	0.00169	CcSEcCtD
Buspirone—Rash—Niacin—atherosclerosis	0.00027	0.00168	CcSEcCtD
Buspirone—Dermatitis—Niacin—atherosclerosis	0.00027	0.00168	CcSEcCtD
Buspirone—Headache—Niacin—atherosclerosis	0.000269	0.00167	CcSEcCtD
Buspirone—Vomiting—Pravastatin—atherosclerosis	0.000269	0.00167	CcSEcCtD
Buspirone—Rash—Pravastatin—atherosclerosis	0.000266	0.00165	CcSEcCtD
Buspirone—Dermatitis—Pravastatin—atherosclerosis	0.000266	0.00165	CcSEcCtD
Buspirone—Headache—Pravastatin—atherosclerosis	0.000265	0.00164	CcSEcCtD
Buspirone—Nausea—Niacin—atherosclerosis	0.000255	0.00158	CcSEcCtD
Buspirone—Nausea—Pravastatin—atherosclerosis	0.000251	0.00156	CcSEcCtD
Buspirone—HTR2A—connective tissue—atherosclerosis	0.000229	0.0216	CbGeAlD
Buspirone—CYP3A5—adipose tissue—atherosclerosis	0.000217	0.0204	CbGeAlD
Buspirone—HTR2A—cardiovascular system—atherosclerosis	0.0002	0.0188	CbGeAlD
Buspirone—CYP3A5—liver—atherosclerosis	0.000152	0.0143	CbGeAlD
Buspirone—ABCB1—cardiovascular system—atherosclerosis	0.000131	0.0123	CbGeAlD
Buspirone—HTR2A—liver—atherosclerosis	0.000123	0.0116	CbGeAlD
Buspirone—ABCB1—adipose tissue—atherosclerosis	0.000115	0.0108	CbGeAlD
Buspirone—CYP3A4—liver—atherosclerosis	0.000114	0.0107	CbGeAlD
Buspirone—CYP2D6—liver—atherosclerosis	0.000112	0.0106	CbGeAlD
Buspirone—ABCB1—liver—atherosclerosis	8.09e-05	0.00761	CbGeAlD
Buspirone—HTR2B—Signaling Pathways—PIK3CG—atherosclerosis	1.15e-05	0.000141	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF2—atherosclerosis	1.14e-05	0.000141	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—HMGCR—atherosclerosis	1.14e-05	0.000141	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.14e-05	0.00014	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—APOB—atherosclerosis	1.13e-05	0.000139	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—ESR1—atherosclerosis	1.13e-05	0.000139	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Buspirone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—F2—atherosclerosis	1.11e-05	0.000137	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EDN1—atherosclerosis	1.11e-05	0.000137	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APOB—atherosclerosis	1.11e-05	0.000137	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—APOB—atherosclerosis	1.11e-05	0.000136	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.11e-05	0.000136	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCL5—atherosclerosis	1.1e-05	0.000136	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	1.1e-05	0.000136	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—MAPK3—atherosclerosis	1.1e-05	0.000135	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EDN1—atherosclerosis	1.09e-05	0.000135	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCL5—atherosclerosis	1.08e-05	0.000134	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—INS—atherosclerosis	1.08e-05	0.000134	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—LPL—atherosclerosis	1.08e-05	0.000133	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.08e-05	0.000133	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	1.08e-05	0.000133	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.08e-05	0.000132	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PPARG—atherosclerosis	1.07e-05	0.000132	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCL2—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CG—atherosclerosis	1.07e-05	0.000131	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.06e-05	0.000131	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.06e-05	0.000131	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.06e-05	0.000131	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.06e-05	0.000131	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—LPL—atherosclerosis	1.06e-05	0.000131	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—LPL—atherosclerosis	1.06e-05	0.00013	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AGT—atherosclerosis	1.05e-05	0.000129	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.05e-05	0.000129	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IGF1—atherosclerosis	1.05e-05	0.000129	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PRKCG—atherosclerosis	1.05e-05	0.000129	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—INS—atherosclerosis	1.05e-05	0.000129	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—GPX1—atherosclerosis	1.03e-05	0.000127	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	1.03e-05	0.000127	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—APOE—atherosclerosis	1.03e-05	0.000127	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—LEP—atherosclerosis	1.03e-05	0.000127	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SPP1—atherosclerosis	1.02e-05	0.000126	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—MAPK3—atherosclerosis	1.02e-05	0.000126	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CAV1—atherosclerosis	1.02e-05	0.000126	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—APOA1—atherosclerosis	1.02e-05	0.000125	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ABCA1—atherosclerosis	1.02e-05	0.000125	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	1.02e-05	0.000125	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—LPA—atherosclerosis	1.01e-05	0.000125	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—INS—atherosclerosis	1.01e-05	0.000124	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CD36—atherosclerosis	1.01e-05	0.000124	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SPP1—atherosclerosis	1e-05	0.000124	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	1e-05	0.000123	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SERPINE1—atherosclerosis	9.96e-06	0.000123	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCL2—atherosclerosis	9.93e-06	0.000122	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ESR1—atherosclerosis	9.83e-06	0.000121	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—BGN—atherosclerosis	9.82e-06	0.000121	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IGF1—atherosclerosis	9.76e-06	0.00012	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOA5—atherosclerosis	9.72e-06	0.00012	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—F2—atherosclerosis	9.71e-06	0.00012	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—ALB—atherosclerosis	9.61e-06	0.000118	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.59e-06	0.000118	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—MTHFR—atherosclerosis	9.52e-06	0.000117	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NOS3—atherosclerosis	9.51e-06	0.000117	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PDGFB—atherosclerosis	9.45e-06	0.000116	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.36e-06	0.000115	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PPARA—atherosclerosis	9.34e-06	0.000115	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	9.3e-06	0.000114	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	9.29e-06	0.000114	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SERPINE1—atherosclerosis	9.27e-06	0.000114	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AGT—atherosclerosis	9.22e-06	0.000114	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—NOS3—atherosclerosis	9.19e-06	0.000113	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AGT—atherosclerosis	9.08e-06	0.000112	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AGT—atherosclerosis	9.05e-06	0.000111	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.04e-06	0.000111	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—LEP—atherosclerosis	9.04e-06	0.000111	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—APOE—atherosclerosis	9.04e-06	0.000111	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CAV1—atherosclerosis	8.95e-06	0.00011	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—APOA1—atherosclerosis	8.93e-06	0.00011	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	8.9e-06	0.00011	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APOE—atherosclerosis	8.89e-06	0.00011	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—LEP—atherosclerosis	8.89e-06	0.00011	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—APOE—atherosclerosis	8.87e-06	0.000109	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NOS3—atherosclerosis	8.85e-06	0.000109	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CAV1—atherosclerosis	8.81e-06	0.000108	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—INS—atherosclerosis	8.79e-06	0.000108	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APOA1—atherosclerosis	8.79e-06	0.000108	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CAV1—atherosclerosis	8.78e-06	0.000108	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—APOA1—atherosclerosis	8.76e-06	0.000108	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—HMOX1—atherosclerosis	8.73e-06	0.000107	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCL2—atherosclerosis	8.65e-06	0.000107	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ESR1—atherosclerosis	8.63e-06	0.000106	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—F2—atherosclerosis	8.52e-06	0.000105	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IGF1—atherosclerosis	8.51e-06	0.000105	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ESR1—atherosclerosis	8.49e-06	0.000105	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CXCL8—atherosclerosis	8.43e-06	0.000104	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTGS2—atherosclerosis	8.4e-06	0.000103	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—F2—atherosclerosis	8.39e-06	0.000103	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APOB—atherosclerosis	8.36e-06	0.000103	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.22e-06	0.000101	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	8.16e-06	0.0001	CbGpPWpGaD
Buspirone—HTR2B—GPCR downstream signaling—AKT1—atherosclerosis	8.15e-06	0.0001	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GSTM1—atherosclerosis	8.13e-06	0.0001	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.11e-06	9.99e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	8.08e-06	9.95e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—LIPC—atherosclerosis	8.06e-06	9.92e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	8.03e-06	9.88e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL6—atherosclerosis	8.02e-06	9.88e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOC3—atherosclerosis	8.01e-06	9.86e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8e-06	9.85e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—LPL—atherosclerosis	7.98e-06	9.83e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—LDLR—atherosclerosis	7.96e-06	9.8e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APOB—atherosclerosis	7.88e-06	9.7e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CXCL8—atherosclerosis	7.85e-06	9.67e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	7.81e-06	9.62e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—GPX1—atherosclerosis	7.79e-06	9.59e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CETP—atherosclerosis	7.77e-06	9.57e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PPARG—atherosclerosis	7.72e-06	9.51e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—INS—atherosclerosis	7.72e-06	9.51e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NOS3—atherosclerosis	7.71e-06	9.5e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	7.69e-06	9.46e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.66e-06	9.44e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—atherosclerosis	7.63e-06	9.4e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—INS—atherosclerosis	7.6e-06	9.35e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCL2—atherosclerosis	7.6e-06	9.35e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CD36—atherosclerosis	7.58e-06	9.34e-05	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	7.58e-06	9.34e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—INS—atherosclerosis	7.57e-06	9.33e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	7.55e-06	9.3e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—LPL—atherosclerosis	7.52e-06	9.26e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCL2—atherosclerosis	7.47e-06	9.2e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IGF1—atherosclerosis	7.47e-06	9.2e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL6—atherosclerosis	7.46e-06	9.19e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.45e-06	9.17e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	7.42e-06	9.14e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	7.4e-06	9.11e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IGF1—atherosclerosis	7.35e-06	9.05e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GPX1—atherosclerosis	7.34e-06	9.04e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—MTHFR—atherosclerosis	7.19e-06	8.85e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CD36—atherosclerosis	7.15e-06	8.8e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—atherosclerosis	7.1e-06	8.74e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	7.09e-06	8.73e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PPARA—atherosclerosis	7.05e-06	8.68e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.03e-06	8.66e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NFKB1—atherosclerosis	7.02e-06	8.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	6.98e-06	8.59e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ALB—atherosclerosis	6.94e-06	8.55e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK8—atherosclerosis	6.9e-06	8.5e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—AKT1—atherosclerosis	6.89e-06	8.48e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	6.85e-06	8.44e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	6.84e-06	8.42e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AGT—atherosclerosis	6.83e-06	8.41e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—atherosclerosis	6.78e-06	8.35e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.77e-06	8.34e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NOS3—atherosclerosis	6.77e-06	8.34e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APOE—atherosclerosis	6.69e-06	8.24e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NOS3—atherosclerosis	6.66e-06	8.2e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PPARA—atherosclerosis	6.64e-06	8.18e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—NOS3—atherosclerosis	6.64e-06	8.18e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CAV1—atherosclerosis	6.63e-06	8.16e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APOA1—atherosclerosis	6.61e-06	8.14e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	6.61e-06	8.14e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL6—atherosclerosis	6.5e-06	8.01e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	6.48e-06	7.98e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AGT—atherosclerosis	6.43e-06	7.92e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—atherosclerosis	6.37e-06	7.85e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—atherosclerosis	6.31e-06	7.77e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APOE—atherosclerosis	6.3e-06	7.76e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	6.29e-06	7.74e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.27e-06	7.72e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CAV1—atherosclerosis	6.25e-06	7.69e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APOA1—atherosclerosis	6.23e-06	7.67e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—atherosclerosis	6.19e-06	7.62e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	6.12e-06	7.54e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.08e-06	7.48e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.04e-06	7.44e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK3—atherosclerosis	6.03e-06	7.43e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	6.02e-06	7.41e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—atherosclerosis	6.01e-06	7.4e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	6e-06	7.39e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	5.91e-06	7.28e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TGFB1—atherosclerosis	5.85e-06	7.2e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PPARG—atherosclerosis	5.83e-06	7.18e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	5.8e-06	7.14e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—INS—atherosclerosis	5.72e-06	7.04e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL6—atherosclerosis	5.71e-06	7.03e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	5.71e-06	7.03e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.69e-06	7.01e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL6—atherosclerosis	5.62e-06	6.92e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	5.56e-06	6.84e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—atherosclerosis	5.5e-06	6.77e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PPARG—atherosclerosis	5.49e-06	6.76e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—atherosclerosis	5.43e-06	6.69e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—INS—atherosclerosis	5.39e-06	6.63e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.38e-06	6.62e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NFKB1—atherosclerosis	5.37e-06	6.62e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—atherosclerosis	5.34e-06	6.58e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	5.29e-06	6.51e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK8—atherosclerosis	5.28e-06	6.51e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—AKT1—atherosclerosis	5.27e-06	6.49e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	5.26e-06	6.47e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALB—atherosclerosis	5.24e-06	6.45e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	5.2e-06	6.4e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	5.18e-06	6.38e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOB—atherosclerosis	5.15e-06	6.34e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	5.1e-06	6.28e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—NOS3—atherosclerosis	5.01e-06	6.17e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.01e-06	6.17e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALB—atherosclerosis	4.94e-06	6.08e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—LPL—atherosclerosis	4.92e-06	6.06e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—atherosclerosis	4.88e-06	6.01e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—atherosclerosis	4.83e-06	5.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	4.8e-06	5.91e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GPX1—atherosclerosis	4.8e-06	5.91e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—atherosclerosis	4.75e-06	5.85e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL6—atherosclerosis	4.74e-06	5.83e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—NOS3—atherosclerosis	4.72e-06	5.82e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CD36—atherosclerosis	4.67e-06	5.75e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK3—atherosclerosis	4.61e-06	5.68e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—atherosclerosis	4.58e-06	5.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	4.54e-06	5.59e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TGFB1—atherosclerosis	4.48e-06	5.51e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.43e-06	5.45e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL6—atherosclerosis	4.41e-06	5.43e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	4.41e-06	5.42e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—AKT1—atherosclerosis	4.37e-06	5.38e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPARA—atherosclerosis	4.34e-06	5.35e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.32e-06	5.32e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AKT1—atherosclerosis	4.22e-06	5.2e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AGT—atherosclerosis	4.21e-06	5.18e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOE—atherosclerosis	4.12e-06	5.08e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CAV1—atherosclerosis	4.08e-06	5.03e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOA1—atherosclerosis	4.07e-06	5.02e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—AKT1—atherosclerosis	4.07e-06	5.01e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL6—atherosclerosis	3.84e-06	4.73e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.72e-06	4.58e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.59e-06	4.42e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AKT1—atherosclerosis	3.54e-06	4.37e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—INS—atherosclerosis	3.52e-06	4.34e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6—atherosclerosis	3.37e-06	4.15e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6—atherosclerosis	3.32e-06	4.09e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALB—atherosclerosis	3.23e-06	3.98e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT1—atherosclerosis	3.11e-06	3.83e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NOS3—atherosclerosis	3.09e-06	3.8e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT1—atherosclerosis	3.06e-06	3.77e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AKT1—atherosclerosis	3.05e-06	3.76e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.82e-06	3.48e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AKT1—atherosclerosis	2.3e-06	2.84e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AKT1—atherosclerosis	2.17e-06	2.67e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.42e-06	1.75e-05	CbGpPWpGaD
